---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-031526"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2023-09-01T23:59:59+00:00"
generated_at: "2026-06-11T00:51:44.315395+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences enters $10M ATM equity distribution agreement with Canaccord Genuity

## Summary
- Initial offering limited to $2,392,514 due to public float restrictions under Form S-3 as of September 1, 2023.
- Canaccord receives 3.0% commission on gross sales; Company to reimburse certain expenses.
- Net proceeds for general corporate purposes: R&D, working capital, debt reduction, acquisitions.
- Shares sold under existing effective shelf registration statement (File No. 333-257690).
- Agreement includes customary representations, warranties, and indemnification provisions.

## SEC filing metadata
- accession: 0001493152-23-031526
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2023-09-01T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315223031526/0001493152-23-031526-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315223031526/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-031526
- JSON: https://secwatch.observer/filing/0001493152-23-031526.json
- Plain text: https://secwatch.observer/filing/0001493152-23-031526.txt

## Key facts
- Material Agreements
  Enveric Biosciences, Inc. entered into Equity Distribution Agreement with Canaccord Genuity LLC valued at up to $10.0 million (effective 2023-09-01).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Canaccord Genuity LLC
  - Value: up to $10.0 million
  - Effective: 2023-09-01
  source text: On September 1, 2023, Enveric Biosciences, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Distribution Agreement”), with Canaccord Genuity LLC (“Canaccord”), pursuant to which the Company may offer and sell from time to time, through Canaccord as sales agent and/or principal, shares of common stock of the Company, par value $0.01 per share (the “Common Stock”), having an aggregate offering price of up to $10.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/890821/000149315223031526/0001493152-23-031526-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.